Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma

Joshua E. Kilgore(University of North Carolina at Chapel Hill), John F. Boggess(University of Kentucky), John T. Soper(University of North Carolina at Chapel Hill), Emily Ko(University of North Carolina at Chapel Hill), Amanda Jackson(University of Cincinnati), Paola A. Gehrig(University of North Carolina at Chapel Hill), Linda Van Le(University of North Carolina at Chapel Hill)
Gynecologic Oncology
December 20, 2012
10.1016/j.ygyno.2012.12.020
Cited by 67

Related Papers

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations
|Gynecologic Oncology|2017|409
What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
|Gynecologic Oncology|2008|290